Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Feb 15;116(4):957-66.
doi: 10.1002/cncr.24866.

Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803

Affiliations
Randomized Controlled Trial

Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803

Nadine Jackson McCleary et al. Cancer. .

Abstract

Background: Cigarette smoking has been shown to increase the risk of developing colorectal cancer, particularly smoking early in life. Little is known about the impact of tobacco use on colon cancer recurrence among colon cancer survivors.

Methods: The authors prospectively collected lifetime smoking history from stage III colon cancer patients enrolled in a phase 3 trial via self-report questionnaires during and 6 months after completion of adjuvant chemotherapy. Smoking status was defined as never, current, or past. Lifetime pack-years were defined as number of lifetime packs of cigarettes. Patients were followed for recurrence or death.

Results: Data on smoking history were captured on 1045 patients with stage III colon cancer receiving adjuvant therapy (46% never smokers; 44% past; 10% current). The adjusted hazard ratio (HR) for disease-free survival (DFS) was 0.99 (95% confidence interval [CI], 0.70-1.41), 1.17 (95% CI 0.89-1.55), and 1.22 (95% CI 0.92-1.61) for lifetime pack-years 0-10, 10-20, and 20+, respectively, compared with never smoking (P = .16). In a preplanned exploratory analysis of smoking intensity early in life, the adjusted HR for 12+ pack-years before age 30 years for DFS was 1.37 (95% CI, 1.02-1.84) compared with never smoking (P = .04). The adjusted HR for DFS was 1.18 (95% CI, 0.92-1.50) for past smokers and 1.10 (95% CI, 0.73-1.64) for current smokers, compared with never smokers.

Conclusions: Total tobacco usage early in life may be an important, independent prognostic factor of cancer recurrences and mortality in patients with stage III colon cancer.

Trial registration: ClinicalTrials.gov NCT00003835.

PubMed Disclaimer

Figures

Fig I
Fig I
Disease-free and overall survival by smoking status for never, current and past smokers by time from study entry in years.
Fig I
Fig I
Disease-free and overall survival by smoking status for never, current and past smokers by time from study entry in years.
Fig II
Fig II
Disease-free and overall survival by smoking intensity (pack-years) by time from study entry in years. A = disease-free survival by overall smoking intensity; B = overall survival by time from study entry in years; C = disease-free survival by smoking intensity prior to age 30; D = overall survival by smoking intensity prior to age 30.
Fig II
Fig II
Disease-free and overall survival by smoking intensity (pack-years) by time from study entry in years. A = disease-free survival by overall smoking intensity; B = overall survival by time from study entry in years; C = disease-free survival by smoking intensity prior to age 30; D = overall survival by smoking intensity prior to age 30.
Fig II
Fig II
Disease-free and overall survival by smoking intensity (pack-years) by time from study entry in years. A = disease-free survival by overall smoking intensity; B = overall survival by time from study entry in years; C = disease-free survival by smoking intensity prior to age 30; D = overall survival by smoking intensity prior to age 30.
Fig II
Fig II
Disease-free and overall survival by smoking intensity (pack-years) by time from study entry in years. A = disease-free survival by overall smoking intensity; B = overall survival by time from study entry in years; C = disease-free survival by smoking intensity prior to age 30; D = overall survival by smoking intensity prior to age 30.

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008. pp. 71–96. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005. pp. 74–108. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
    1. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst. 1994. pp. 183–91. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
    1. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst. 2000. pp. 1888–96. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
    1. Heineman EF, Zahm SH, McLaughlin JK, Vaught JB. Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review. Int J Cancer. 1994. pp. 728–38. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed

Publication types

Associated data